1·To investigate the effect of benazepril on expression of cyclin kinase inhibitor P21 CIP1 protein in renal tissue of diabetic rats.
目的：探讨苯那普利对糖尿病大鼠肾组织细胞周期蛋白激酶抑制剂p 21 CIP1蛋白表达的影响。
2·To explore the intensity of inhibitory function of Shenkang injection (SKI), a Chinese herbal recipe, and benazepril on the proliferation of human glomerular mesangial cell (MC).
目的：探讨肾康注射液与苯那普利对人肾小球系膜细胞（MC）增殖的不同抑制作用强度。
3·It is recommended to monitor plasma potassium levels when using benazepril in combination with a potassium sparing diuretic.
建议监测血钾水平时，结合使用了利尿剂钾苯那普利。
4·There was no difference between benazepril postconditioning group and preconditioning group (P>0.05).
苯那普利后处理组和预处理组相比较，差异无统计学意义（P>0.05）。
5·Conclusion: in equal dose consistency, JTTM was superior to Benazepril on the inhibition the proliferation of MC.
结论：在等效剂量浓度下，降糖通脉片对MC的抑制作用优于苯那普利。
1·Medications in this category include benazepril (Lotensin), captopril (Capoten) and enalapril (Vasotec).
这类药物包括贝那普利(洛汀新)、卡托普利(开博通)、依那普利等。
2·OBJECTIVE: To discuss the manifestation characteristics and regularities of adverse drug reactions (ADR) induced by benazepril.
前言：目的：探讨贝那普利不良反应发生的特点及规律。
3·Objective to observe the protective effects on diabetic nephropathy (DN) rats by Xueshuantong injection combined with benazepril and to explore its therapeutic mechanism.
目的观察血栓通注射液联合贝那普利对糖尿病肾病(DN)大鼠肾脏的保护作用，探讨其作用机制。
4·Objective: to explore the clinical effect of benazepril to treat diabetic nephropathy.
目的：探讨贝那普利治疗糖尿病肾病的临床效果。
5·Objective to explore the predict factors of antihypertensive efficacy response to Benazepril treatment in essential hypertension patients.
目的探讨原发性高血压患者贝那普利降压疗效的预测指标。